Ashurst has advised ICBC International Capital Limited. Hanx Biopharmaceuticals (Wuhan) Co., Ltd., a China-based biopharmaceutical company, has successfully completed a global offering amounting to HK$586.3 million,...
Hanx Biopharmaceuticals Completes HK$586 Million Hong Kong IPO
Butong Group Completes HK$781.84 Million Hong Kong IPO
Ashurst has advised the underwriters of Butong Group. Butong Group has completed its global offering and successfully listed its shares on the Main Board of The...


























